Revisão Revisado por pares

Pathophysiology of Inflammatory Bowel Diseases

2020; Massachusetts Medical Society; Volume: 383; Issue: 27 Linguagem: Inglês

10.1056/nejmra2002697

ISSN

1533-4406

Autores

John T. Chang,

Tópico(s)

Gastrointestinal motility and disorders

Resumo

Research on IBDs has identified disrupted immune responses in the gastrointestinal mucosa and putative disruptions in the gut microbiome as causative agents. This work has led to better therapeutic control of IBDs with the use of various antiinflammatory agents.

Referência(s)